Literature DB >> 21168019

The Cox maze IV procedure: predictors of late recurrence.

Ralph J Damiano1, Forrest H Schwartz, Marci S Bailey, Hersh S Maniar, Nabil A Munfakh, Marc R Moon, Richard B Schuessler.   

Abstract

OBJECTIVES: The Cox maze III procedure achieved high cure rates and became the surgical gold standard for the treatment of atrial fibrillation. Because of its invasiveness, a more simplified ablation-assisted procedure, the Cox maze IV procedure, has been performed at our institution since January 2002. The study examined multiple preoperative and perioperative variables to determine predictors of late recurrence.
METHODS: Data were collected prospectively on 282 patients who underwent the Cox maze IV procedure from January 2002 through December 2009. Forty-two percent of patients had paroxysmal and 58% had either persistent or long-standing persistent atrial fibrillation. All patients were available for follow-up. Follow-up included electrocardiograms in all patients. Since 2006, 24-hour Holter monitoring was obtained in 94% of patients at 3, 6, and 12 months. Data were analyzed by means of logistic regression analysis at 12 months, with 13 preoperative and perioperative variables used as covariates.
RESULTS: Sixty-six percent of patients had a concomitant procedure. After an ablation-assisted Cox maze procedure, the freedom from atrial fibrillation was 89%, 93%, and 89% at 3, 6, and 12 months, respectively. The freedom from both atrial fibrillation and antiarrhythmic drugs was 63%, 79%, and 78% at 3, 6, and 12 months, respectively. The risk factors for atrial fibrillation recurrence at 1 year were enlarged left atrial diameter (P = .027), failure to isolate the entire posterior left atrium (P = .022), and early atrial tachyarrhythmias (P = .010).
CONCLUSIONS: The Cox maze IV procedure has a high success rate at 1 year, even with improved follow-up and stricter definitions of failure. In patients with large left atria, there might be a need for more extensive size reduction or expanded lesion sets.
Copyright © 2011 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21168019      PMCID: PMC3035158          DOI: 10.1016/j.jtcvs.2010.08.067

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  20 in total

Review 1.  Cox-Maze procedure for atrial fibrillation: Mayo Clinic experience.

Authors:  H V Schaff; J A Dearani; R C Daly; T A Orszulak; G K Danielson
Journal:  Semin Thorac Cardiovasc Surg       Date:  2000-01

2.  The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures.

Authors:  Sunil M Prasad; Hersh S Maniar; Cindy J Camillo; Richard B Schuessler; John P Boineau; Thoralf M Sundt; James L Cox; Ralph J Damiano
Journal:  J Thorac Cardiovasc Surg       Date:  2003-12       Impact factor: 5.209

3.  Importance of geometry and refractory period in sustaining atrial fibrillation: testing the critical mass hypothesis.

Authors:  Gregory D Byrd; Sandip M Prasad; Crystal M Ripplinger; T Ryan Cassilly; Richard B Schuessler; John P Boineau; Ralph J Damiano
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

Review 4.  HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Josep Brugada; Douglas L Packer; Riccardo Cappato; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; David E Haines; Michel Haissaguerre; Yoshito Iesaka; Warren Jackman; Pierre Jais; Hans Kottkamp; Karl Heinz Kuck; Bruce D Lindsay; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Andrea Natale; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Jeremy N Ruskin; Richard J Shemin
Journal:  Heart Rhythm       Date:  2007-04-30       Impact factor: 6.343

5.  The Cox maze procedure in mitral valve disease: predictors of recurrent atrial fibrillation.

Authors:  A Marc Gillinov; Jon Sirak; Eugene H Blackstone; Patrick M McCarthy; Jeevanantham Rajeswaran; Gosta Pettersson; F Joseph Sabik; Lars G Svensson; Jose L Navia; Delos M Cosgrove; Nassir Marrouche; Andrea Natale
Journal:  J Thorac Cardiovasc Surg       Date:  2005-10-26       Impact factor: 5.209

6.  Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation.

Authors:  C Pappone; G Oreto; S Rosanio; G Vicedomini; M Tocchi; F Gugliotta; A Salvati; C Dicandia; M P Calabrò; P Mazzone; E Ficarra; C Di Gioia; S Gulletta; S Nardi; V Santinelli; S Benussi; O Alfieri
Journal:  Circulation       Date:  2001-11-20       Impact factor: 29.690

7.  Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation.

Authors:  Yosuke Ishii; Richard B Schuessler; Sydney L Gaynor; Kiyomi Yamada; Annabel S Fu; John P Boineau; Ralph J Damiano
Journal:  Circulation       Date:  2005-05-31       Impact factor: 29.690

8.  A new era in the surgical treatment of atrial fibrillation: the impact of ablation technology and lesion set on procedural efficacy.

Authors:  Spencer J Melby; Andreas Zierer; Marci S Bailey; James L Cox; Jennifer S Lawton; Nabil Munfakh; Traves D Crabtree; Nader Moazami; Charles B Huddleston; Marc R Moon; Ralph J Damiano
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

9.  Improved success rate of the maze procedure in mitral valve disease by new criteria for patients' selection.

Authors:  J Kobayashi; Y Kosakai; K Nakano; Y Sasako; K Eishi; F Yamamoto
Journal:  Eur J Cardiothorac Surg       Date:  1998-03       Impact factor: 4.191

10.  Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation.

Authors:  Hakan Oral; Christoph Scharf; Aman Chugh; Burr Hall; Peter Cheung; Eric Good; Srikar Veerareddy; Frank Pelosi; Fred Morady
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

View more
  66 in total

1.  Is pulmonary vein isolation effective for permanent atrial fibrillation?

Authors:  Yosuke Ishii
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-02-12

2.  Cox-Maze IV results for patients with lone atrial fibrillation versus concomitant mitral disease.

Authors:  Lindsey L Saint; Marci S Bailey; Sunil Prasad; Tracey J Guthrie; Jennifer Bell; Marc R Moon; Jennifer S Lawton; Nabil A Munfakh; Richard B Schuessler; Ralph J Damiano; Hersh S Maniar
Journal:  Ann Thorac Surg       Date:  2012-02-02       Impact factor: 4.330

3.  Maze permutations during minimally invasive mitral valve surgery.

Authors:  Anson M Lee
Journal:  Ann Cardiothorac Surg       Date:  2015-09

4.  Concomitant Cox-Maze IV techniques during mitral valve surgery.

Authors:  Christopher P Lawrance; Matthew C Henn; Ralph J Damiano
Journal:  Ann Cardiothorac Surg       Date:  2015-09

5.  Treatment Complications of Atrial Fibrillation and Their Management.

Authors:  Allan Mattia; Joshua Newman; Frank Manetta
Journal:  Int J Angiol       Date:  2020-03-05

6.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Heart Rhythm       Date:  2017-05-12       Impact factor: 6.343

7.  eComment. The modifed maze procedure as concomitant surgery: the impact of left atrial size.

Authors:  Bachar El Oumeiri; Frederic Vanden Eynden; Guido Van Nooten
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-02

8.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; José Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  Heart Rhythm       Date:  2012-03-01       Impact factor: 6.343

9.  The Electrophysiologic Effects of Acute Mitral Regurgitation in a Canine Model.

Authors:  Christopher P Lawrance; Matthew C Henn; Jacob R Miller; Michael A Kopek; Andrew J Zhang; Richard B Schuessler; Ralph J Damiano
Journal:  Ann Thorac Surg       Date:  2016-10-15       Impact factor: 4.330

Review 10.  Ablation of long-standing persistent atrial fibrillation.

Authors:  Behram P Mody; Anoshia Raza; Jason Jacobson; Sei Iwai; Daniel Frenkel; Rhadames Rojas; Wilbert S Aronow
Journal:  Ann Transl Med       Date:  2017-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.